Mike Withrow is founder of North American BioExtracts Inc., an extraction technology equipment company and Biocell Labs Inc. and has served as VP of Business Development in two nutracuetical companies. He brings an in-depth knowledge of supplement innovation, ingredients, is well connected in the ingredients and natural health product industry. Mike is a valued member of any team and is capable of managing intellectual property, ingredient research, extraction technologies and formulation. He also has a keen understanding of animal and human testing, grant funding, and product and market development of a company's nutraceutical ingredient and finished product strategies. Mike is a board member of a publicly traded mining and exploration company and is a board Member of the Saskatoon Berry Council of Canada.

Mr. Withrow continues to consult to nutracuetical companies and has been instrumental in helping companies in very different industries receive over $3,800,000 in grant money. He was a founding partner of BFuel Canada Ltd., a planned bio-diesel facility in Lethbridge AB. Prior to BFuel Mike co-founded CBN Systems Inc., a company that unified and patented all known color spaces via the "CBN Code" and linked spectrophotometry to user friendly designer software and a colour formulation system. Early in his career Mike founded PowerTrader Inc., which was the first company to offer real-time financial data via a stand-alone MS Windows platform and on the Internet. Prior to that Mike was a floor trader on the Vancouver Stock Exchange.

Dr. Fealey is a partner at OTC Nutrition LLC and formerly held the position of Senior VP Global Food and Beverage Strategic Planning for Procter and Gamble Company.. Additionally, he has had senior R&D and Strategic leadership responsibilities with The Coca-Cola Company and recently served as Senior VP Chief Innovation Officer of Martek Bioscience Corporation, a leading nutrition biotechnology company based in Maryland, USA. Dr. Fealey has over 30 years of combined R&D and general management experience in all aspects of technology management and global strategic planning. He brings extensive business experience, knowledge, and a broad network, both private companies and public institutions, of personal contacts in all regions of the world. Dr. Fealey was a key contributor to the highly successful global expansion of the Pringles brand as well as other well-known consumer product brands. He has extensive experience in the business of foods and beverages including suppliers and external capabilities and to the global academic and regulatory communities. Dr. Fealey holds a PhD in Physical Chemistry from Georgetown University and MBA from University of Chicago.

Douglas J. Sorocco practices law in the areas of intellectual property, technology, licensing, life sciences and patents and is involved in counseling and transactional work involving all aspects of intellectual property. He is ranked among Oklahoma's top intellectual property practitioners by the highly regarded Chambers USA: America's Leading Lawyers for Business. Mr. Sorocco was recently selected by attorney peers for inclusion in Oklahoma Super Lawyers--Rising Stars Edition (2010).

Mr. Sorocco 's scientific background has focused on all areas of biotechnology and life sciences (including molecular biology, cell biology, glycobiology, biochemistry, developmental biology, immunology, microbiology, virology, and genetics; pharmaceutical compositions; molecular diagnostics and techniques; medical devices and equipment) as well as chemistry and chemical engineering.

Mr. Sorocco has significant experience in providing strategic and tactical intellectual property counsel to individual clients, universities, large pharmaceutical and manufacturing companies, and start-up biotechnology companies. He is an adjunct faculty member at the Oklahoma City University School of Law and the Physiology Department at Oklahoma University Health Sciences Center.

Phil Hardy, Ph.D. Dr. Hardy is co-founder of North American BioExtracts and Pine River Petrochemicals and has been a biotechnology contractor for several biomedical companies including: Ischemia Technologies, Thermo Electron, Inverness Medical Innovations and Accera Inc. He holds a PhD in Biochemistry (neurochemistry) from the University of Queensland, Australia, and did a post doctorate at the University of Colorado in cancer gene therapy. Dr. Hardy has R&D experience in molecular and cellular biology, in vitro diagnostics and pharmaceutical drug development, and FDA regulated Operations experience in these fields.
Over the past five years he has refocused on the algal and phyto-nutrient sectors, performing business development, funding, project planning, project management and manufacturing activities with companies including Pine River Petrochemicals, North American BioExtracts, Canadian Pacific Algae, CinrG Labs and now Abattis Biologix.

Mr. Al Homsi is ASSISTANT MANAGER, Financial Services for Pricewaterhouse Coopers, Riyadh, Saudi Arabia. He has been with PwC for 4 years and has served as a senior consultant for the company with a focus on Merger and Acquisition activity at a C Level. Yazan's recent assignments include several financial due diligences and valuations for some of the largest IPOs in the GCC market, covering a large group of companies in the automotive, real estate, bottling and general trading sectors and leading companies in the health-care, publishing & media, vehicle rental and real estate development sectors in Saudi Arabia.